Platelet activating factor antagonists: imidazopyridine indoles
US5486525A · kind A · utility
74Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 5, 1994 |
| Grant date | Jan 23, 1996 |
| Priority date | — |
| Expiry date | Dec 5, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula ##STR1## and the pharmaceutically acceptable salts thereof which are potent antagonists of PAF and are useful in the treatment of PAF-related disorders including asthma, shock, respiratory distress syndrome, acute inflammation, transplanted organ rejection, gastrointestinal ulceration, allergic skin diseases, delayed cellular immunity, parturition, fetal lung maturation, and cellular differentiation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.